AceBiome: CEO on the science behind BNRThin and functional probiotics for weight loss
31 Jul 2025 | AceBiome
Myeong Hee Kim, AceBiome’s CEO, highlights the company’s flagship probiotic strain, Lactobacillus gasseri BNR17, the first probiotic approved in South Korea for body fat reduction. She says the strain leads AceBiome’s science-driven portfolio and shares results from clinical trials on reduced visceral fat and improved gut health. The strain is featured in AceBiome’s BNRThin line, supporting weight management, metabolic health, and GLP-1 users by easing digestive discomfort and preserving muscle mass. The company has also entered the joint health market with a patented plant extract, ParActin.
